Market capitalization | €3.55b |
Enterprise Value | €4.68b |
P/E (TTM) P/E ratio | 30.87 |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 2.34 |
P/S ratio (TTM) P/S ratio | 1.78 |
P/B ratio (TTM) P/B ratio | 2.40 |
Dividend yield | 1.21% |
Last dividend (FY23) | €1.25 |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
15 Analysts have issued a Gerresheimer forecast:
15 Analysts have issued a Gerresheimer forecast:
May '24 |
+/-
%
|
||
Revenue | 2,002 2,002 |
2%
2%
|
|
Gross Profit | 587 587 |
2%
2%
|
|
EBITDA | 422 422 |
3%
3%
|
EBIT (Operating Income) EBIT | 232 232 |
7%
7%
|
Net Profit | 115 115 |
8%
8%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices; Primary Packaging Glass; and Head Office. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The company was founded on November 3, 2004 and is headquartered in Duesseldorf, Germany.
Head office | Germany |
CEO | Dietmar Siemssen |
Employees | 11,660 |
Founded | 1864 |
Website | www.gerresheimer.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.